BR9606521A - Polinucleotídeo purificado e isolado molécula de dna construção de expressão de dna célula hospedeira método para produzir um polipeptídeo humano polipeptídeo purificado e isolado anticorpo e linhagem celular de hibridoma - Google Patents
Polinucleotídeo purificado e isolado molécula de dna construção de expressão de dna célula hospedeira método para produzir um polipeptídeo humano polipeptídeo purificado e isolado anticorpo e linhagem celular de hibridomaInfo
- Publication number
- BR9606521A BR9606521A BR9606521A BR9606521A BR9606521A BR 9606521 A BR9606521 A BR 9606521A BR 9606521 A BR9606521 A BR 9606521A BR 9606521 A BR9606521 A BR 9606521A BR 9606521 A BR9606521 A BR 9606521A
- Authority
- BR
- Brazil
- Prior art keywords
- purified
- produce
- host cell
- cell line
- human polypeptide
- Prior art date
Links
- 108020004414 DNA Proteins 0.000 title 1
- 210000004027 cell Anatomy 0.000 title 1
- 238000010276 construction Methods 0.000 title 1
- 210000004408 hybridoma Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/503,172 US5795735A (en) | 1995-07-17 | 1995-07-17 | Isolated polynucleotides encoding PKA-binding proteins and methods of producing the proteins recombinantly |
| PCT/US1996/011857 WO1997004096A1 (en) | 1995-07-17 | 1996-07-17 | Novel pka-binding proteins and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9606521A true BR9606521A (pt) | 1997-12-23 |
Family
ID=24001004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9606521A BR9606521A (pt) | 1995-07-17 | 1996-07-17 | Polinucleotídeo purificado e isolado molécula de dna construção de expressão de dna célula hospedeira método para produzir um polipeptídeo humano polipeptídeo purificado e isolado anticorpo e linhagem celular de hibridoma |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5795735A (pt) |
| EP (1) | EP0782619A1 (pt) |
| JP (1) | JPH10506798A (pt) |
| CN (1) | CN1165537A (pt) |
| AU (1) | AU713536B2 (pt) |
| BR (1) | BR9606521A (pt) |
| CA (1) | CA2199403C (pt) |
| CZ (1) | CZ71797A3 (pt) |
| FI (1) | FI971085A (pt) |
| HU (1) | HUP9801330A3 (pt) |
| NO (1) | NO971188L (pt) |
| PL (1) | PL319157A1 (pt) |
| SK (1) | SK281021B6 (pt) |
| WO (1) | WO1997004096A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795735A (en) * | 1995-07-17 | 1998-08-18 | Icos Corporation | Isolated polynucleotides encoding PKA-binding proteins and methods of producing the proteins recombinantly |
| EP0862651A2 (en) * | 1995-10-16 | 1998-09-09 | Chiron Corporation | Method of screening for factors that modulate gene expression |
| US7192932B1 (en) | 1997-04-29 | 2007-03-20 | Lauras As | Use of immunomodulating agents |
| NO971997D0 (no) * | 1997-04-29 | 1997-04-29 | Kjetil Tasken | Bruk av immunmodulerende midler |
| US6576080B1 (en) * | 1999-10-20 | 2003-06-10 | Xyron, Inc. | Adhesive transfer device |
| BR0211243A (pt) | 2001-07-20 | 2004-07-27 | Xyron Inc | Aparelho para o processamento de substrato |
| US7112723B2 (en) * | 2004-07-28 | 2006-09-26 | Applied Biotechnology Institute | Globulin 2 regulatory region and method of using same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4568649A (en) * | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
| US5169637A (en) * | 1983-03-24 | 1992-12-08 | The Liposome Company, Inc. | Stable plurilamellar vesicles |
| US5180713A (en) * | 1985-09-27 | 1993-01-19 | Liposome Technology, Inc. | Stabilized liposome/amphotercin B composition and method |
| US4766046A (en) * | 1985-09-27 | 1988-08-23 | Liposome Technology, Inc. | Stabilized liposome/amphotericin composition and method |
| US5252263A (en) * | 1986-06-16 | 1993-10-12 | The Liposome Company, Inc. | Induction of asymmetry in vesicles |
| US5204112A (en) * | 1986-06-16 | 1993-04-20 | The Liposome Company, Inc. | Induction of asymmetry in vesicles |
| US5185154A (en) * | 1989-02-02 | 1993-02-09 | Liposome Technology, Inc. | Method for instant preparation of a drug containing large unilamellar vesicles |
| US5283173A (en) * | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US6080540A (en) * | 1990-04-20 | 2000-06-27 | Cold Spring Harbor Laboratory | Cloning of mammalian genes in microbial organisms and methods for pharmacological screening |
| JP3533215B2 (ja) * | 1990-07-31 | 2004-05-31 | ザ リポソーム カンパニー，インコーポレイテッド | アミノ酸及びペプチドのリポソーム内への蓄積 |
| US5795735A (en) * | 1995-07-17 | 1998-08-18 | Icos Corporation | Isolated polynucleotides encoding PKA-binding proteins and methods of producing the proteins recombinantly |
-
1995
- 1995-07-17 US US08/503,172 patent/US5795735A/en not_active Expired - Fee Related
-
1996
- 1996-07-17 CA CA002199403A patent/CA2199403C/en not_active Expired - Fee Related
- 1996-07-17 EP EP96925352A patent/EP0782619A1/en not_active Withdrawn
- 1996-07-17 CZ CZ97717A patent/CZ71797A3/cs unknown
- 1996-07-17 PL PL96319157A patent/PL319157A1/xx unknown
- 1996-07-17 AU AU65478/96A patent/AU713536B2/en not_active Ceased
- 1996-07-17 HU HU9801330A patent/HUP9801330A3/hu unknown
- 1996-07-17 SK SK328-97A patent/SK281021B6/sk unknown
- 1996-07-17 JP JP9506832A patent/JPH10506798A/ja active Pending
- 1996-07-17 WO PCT/US1996/011857 patent/WO1997004096A1/en not_active Application Discontinuation
- 1996-07-17 BR BR9606521A patent/BR9606521A/pt unknown
- 1996-07-17 CN CN96191059A patent/CN1165537A/zh active Pending
-
1997
- 1997-03-14 NO NO971188A patent/NO971188L/no not_active Application Discontinuation
- 1997-03-14 FI FI971085A patent/FI971085A/fi not_active IP Right Cessation
-
1998
- 1998-08-17 US US09/135,211 patent/US5994304A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI971085A0 (fi) | 1997-03-14 |
| WO1997004096A1 (en) | 1997-02-06 |
| US5994304A (en) | 1999-11-30 |
| PL319157A1 (en) | 1997-07-21 |
| CZ71797A3 (cs) | 1998-01-14 |
| NO971188L (no) | 1997-05-15 |
| CA2199403C (en) | 2001-02-20 |
| SK281021B6 (sk) | 2000-11-07 |
| CA2199403A1 (en) | 1997-02-06 |
| AU6547896A (en) | 1997-02-18 |
| SK32897A3 (en) | 1998-02-04 |
| NO971188D0 (no) | 1997-03-14 |
| JPH10506798A (ja) | 1998-07-07 |
| US5795735A (en) | 1998-08-18 |
| HUP9801330A3 (en) | 2000-11-28 |
| MX9701904A (es) | 1998-05-31 |
| CN1165537A (zh) | 1997-11-19 |
| HUP9801330A2 (hu) | 1998-08-28 |
| FI971085A (fi) | 1997-03-17 |
| EP0782619A1 (en) | 1997-07-09 |
| AU713536B2 (en) | 1999-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9505980A (pt) | Anticorpo monoclonal seu fragmento linhagem de células de hibridoma sequências de aminoácidos e de DNA composição farmacêutica processo para a produção de um anticorpo monoclonal e seu uso | |
| FI960469A (fi) | DNA:ta sekvenssoivia entsyymejä | |
| NO965411D0 (no) | N-terminalt forlengede proteiner uttrykt i gjær | |
| FI973055A (fi) | Soluja yhdistelmä-DNA-adenovirusten tuottamiseksi | |
| CY1108175T1 (el) | ΠΟΛΥΠΕΠΤΙΔΙΟ DcR3, ΟΜΟΛΟΓΟ TNFR | |
| BR9606379A (pt) | Dna recombinante replicavel em células de bactérias corinformes bactérias corineformes processo para produzir l-lisina | |
| DK538485D0 (da) | Rekombinante dna-molekyler | |
| ITMI931534A0 (it) | Metodo di sintesi biologica di peptidi | |
| DE69532847D1 (de) | System zur Seitenanalyse | |
| BR9507678A (pt) | Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura | |
| BR9508666A (pt) | Detecção de sequência de ácido nucléico hipermutável em tecido | |
| EE200000152A (et) | Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon | |
| BR9509890A (pt) | Polipeptídeo sequencia de dna ou rna vetor célula hospedeira e processo para produzir um polipeptídeo | |
| NZ296748A (en) | Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods | |
| DE69608668D1 (de) | Peptide für gewebe- und zellkulturmedien | |
| DE4496581T1 (de) | Nucleinsäure-Sequenzierungsgele | |
| SE8204810D0 (sv) | Recombinant dna molecule, transformed microorganism and process for producing protein a | |
| BR9606521A (pt) | Polinucleotídeo purificado e isolado molécula de dna construção de expressão de dna célula hospedeira método para produzir um polipeptídeo humano polipeptídeo purificado e isolado anticorpo e linhagem celular de hibridoma | |
| MX9909801A (es) | Metodo para separar proteinas de fusion | |
| BR9709721A (pt) | Polinucleotídeo purificado e isolado dna vetor célula hospedeira processo para prodzir quitanase humama para tratar uma infecção fúngica e para reduzir a quantidade de um ant-fúngico não-quitanase fragmento de polipeptídeo de quitanase humama linha de células de hiridoma anticorpo monoclonal e composição farmacéutica | |
| BR9702143A (pt) | Polinucleotídeo purificado e isolado molécula de dna construção de expressão de dna célula hospedeira anticorpo linhagem de células hibridomas e processos para produzir um polipeptídeo para identificar um composto e para isolar um polinucleotídeo | |
| CA2032167A1 (en) | Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene | |
| DE69728897D1 (de) | Saeugetierchemokine | |
| IT1285405B1 (it) | Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto. | |
| BR9606557A (pt) | Anticorpo monoclonal hibridoma polipeptídeo purificado e isolado polinucleotídeo purificado e isolado DNA célula hospedeira e método para produzir o polipeptídeo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) |